Skip to main content
. 2021 Aug 12;9(8):894. doi: 10.3390/vaccines9080894
OS overall survival
GEP gene expression profile
TIS tumor inflammation signature
MHC major histocompatibility class
DC dendritic cells
NK natural killer
PARP poly (ADP-ribose) polymerase
PCA principal component analysis
GR good response